Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Prevnar 13
Biotech
Pfizer's 20-valent pneumococcal vaccine hits goal in infants
After four doses, all 20 serotypes met the statistical noninferiority criteria in a study that compared the candidate to Prevnar 13.
Nick Paul Taylor
Aug 12, 2022 8:00am
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Oct 20, 2020 8:55am
Affinivax banks $120M for vaccines against hospital superbugs
Apr 23, 2020 7:00am
